Peter N. Johnson, Pharm.D., BCPPS, FPPAG, FCCM, FASHP

Professor of Pharmacy Practice

Pharmacy Clinical & Admin Sci

Phone (405) 271-2730

Fax (405) 271-6750

Office O'Donoghue Research Bldg; 1122 NE 13th St., Ste. 4415, OKC 73117

Email Peter-Johnson@ouhsc.edu


Summary

  • President's Associate Presidential Professor
  • Director, PGY2 Pediatric Pharmacy Residency
  • Director, Pediatric Pharmacotherapy Degree Option



Publications & Presentations

    121. Bulkley C F, Johnson P N, Henry E, Harrison D, Lewis T V, Miller J L. Bumetanide continuous-infusion dosing in critically ill pediatric patients. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 2012; 69 : 1458, 1460-1

    122. Johnson P N, Miller J L, Harrison D. Evaluation of initial methadone dosing for prevention of iatrogenic opioid abstinence syndrome in children. Journal of Pediatric Intensive Care. 2012; 2 : 105-113

    123. Ibach B W, Oldham M M, Johnson P N, Turman M A, Lewis T V. Clindamycin-associated hyperphosphatemia in a child with renal dysfunction. Journal of Pharmacy Technology. 2012; 28 : 124-128

    124. Bernie B R, Johnson P N, Smith T, Patel S. Pediatric Pharmacy Group Position Statement: Pediatric pharmacists' participation in cardiopulmonary resucitation events. 2012

    125. Johnson P N, Boyles K A, Miller J L. Selection of the initial methadone regimen for the management of iatrogenic opioid abstinence syndrome in critically ill children. Pharmacotherapy. 2012; 32 : 148-57




Grants

    1. Evaluation of caffeine dosing regimens and the impact of developmental pharmacokinetics in neonates with apnea of prematurity. Misc Non-Federal. Start Date: 2020. End Date: 2021.

    2. Characterization of fentanyl metabolic and renal elimination pathways in children less than two years of age. Misc Non-Federal. Start Date: 2018. End Date: 2020.

    3. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.

    4. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.

    5. Comparison of amikacin pharmacokinetics in neonates pre- and post- a dosing protocol change. Misc Non-Federal. Start Date: 2014. End Date: 2015.




Awards and Honors

<< 5 6 7 8
                                                                                            36. Mississippi Society of Health-System Pharmacists. Student Achievement Award. Date: 2004.  

                                                                                            37. United States Public Health Service. Excellence in Public Health Pharmacy Practice Award. Date: 2004.  

<< 5 6 7 8



Education

                                                                                            1.  Degree: PGY2 Pediatric Pharmacy Residency. Kentucky Children's Hospital and University of Kentucky Chandler Medical Center. Date: 2006.  

                                                                                            2.  Degree: PGY1 Pharmacy Residency. University of Kentucky Chandler Medical Center. Date: 2005.  

                                                                                            3.  Degree: PharmD. University of Mississippi School of Pharmacy. Date: 2004.  

                                                                                            4.  Degree: BS. University of Mississippi School of Pharmacy. Date: 2002.  




Administrative Assignments


no results